tradingkey.logo

Stevanato Group SpA

STVN
查看詳細走勢圖
20.550USD
+0.030+0.15%
收盤 12/19, 16:00美東報價延遲15分鐘
5.61B總市值
46.74本益比TTM

Stevanato Group SpA

20.550
+0.030+0.15%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.15%

5天

-1.30%

1月

-2.88%

6月

-11.76%

今年開始到現在

-5.69%

1年

-0.05%

查看詳細走勢圖

TradingKey Stevanato Group SpA股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Stevanato Group SpA當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名63/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價28.99。中期看,股價處於下降通道。近一個月,市場表現較差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Stevanato Group SpA評分

相關信息

行業排名
63 / 208
全市場排名
159 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 11 分析師
買入
評級
28.993
目標均價
+34.98%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Stevanato Group SpA亮點

亮點風險
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
高分紅
公司屬於高分紅公司,最新股息支付率12.27%
估值低估
公司最新PE估值46.70,處於3年歷史低位
機構減倉
最新機構持股55.80M股,環比減少15.95%
景順投資公司持倉
明星投資者景順投資公司持倉,最新持倉945.00股

Stevanato Group SpA新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Stevanato Group SpA簡介

Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
公司代碼STVN
公司Stevanato Group SpA
CEOStevanato (Franco)
網址https://www.stevanatogroup.com/

常見問題

Stevanato Group SpA(STVN)的當前股價是多少?

Stevanato Group SpA(STVN)的當前股價是 20.550。

Stevanato Group SpA 的股票代碼是什麼?

Stevanato Group SpA的股票代碼是STVN。

Stevanato Group SpA股票的52週最高點是多少?

Stevanato Group SpA股票的52週最高點是28.000。

Stevanato Group SpA股票的52週最低點是多少?

Stevanato Group SpA股票的52週最低點是17.810。

Stevanato Group SpA的市值是多少?

Stevanato Group SpA的市值是5.61B。

Stevanato Group SpA的淨利潤是多少?

Stevanato Group SpA的淨利潤為117.78M。

現在Stevanato Group SpA(STVN)的股票是買入、持有還是賣出?

根據分析師評級,Stevanato Group SpA(STVN)的總體評級為買入,目標價格為28.993。

Stevanato Group SpA(STVN)股票的每股收益(EPS TTM)是多少

Stevanato Group SpA(STVN)股票的每股收益(EPS TTM)是0.440。
KeyAI